开发一种可扩展的半合成介质,用于生产高产喉毒素,使用最终查设计和创新的统计优化方法
Prashant R Chawla1, Uma Addepally1
1Center of Biotechnology, University College of Engineering, Science and Technology, JNTUH, Hyderabad, India.
Preparative biochemistry & biotechnology
|February 21, 2025
概括
优化半合成介质可以增强用于疫苗的喉毒素 (DT) 生产. 这项研究确定了提高DT产量的关键营养素和条件,使大规模疫苗生产更加可行.
科学领域:
- 微生物学 微生物学
- 生物技术是生物技术.
- 疫苗开发 疫苗开发
背景情况:
- 由于*Corynebacterium diphtheriae*引起的疹仍然是严重的健康威胁,特别是对儿童来说.
- 有效的免疫依赖于足够的喉毒素 (DT) 产量来制造疫苗.
- 目前使用标准介质的DT生产方法面临着污染和批量变化等挑战.
研究的目的:
- 为了优化半合成媒介的组成,以提高喉毒素 (DT) 产量.
- 通过系统选设计,识别影响DT产量的关键营养成分.
- 开发一种具有成本效益和可扩展的DT生产方法.
主要方法:
- 利用确定的选设计 (DSD) 方法来优化半合成介质.
- 选了11个组件,以确定那些对DT生产产生重大影响的组件.
- 采用统计建模 (R2 = 0.9820) 来预测基于媒体组成的DT收益率.
主要成果:
- 确定了NZ-胺,N1试和马尔托斯作为DT生产的关键营养素.
- 优化条件表明较低的NZ-胺与适度的麦芽糖和 N1为最大的DT产量.
- 在验证实验中获得了174Lf/mL的DT产量,与标准生产产量相比.
结论:
- 优化的半合成介质为喉毒素生产提供了一种可行的,具有成本效益和可扩展的替代方案.
- 这种方法解决了传统媒体的局限性,有可能改善疫苗的可访问性.
- 这项研究证明了DSD在优化生物过程中的有效性,以提高疫苗成分产量.
更多相关视频
12:16High Throughput Quantitative Expression Screening and Purification Applied to Recombinant Disulfide-rich Venom Proteins Produced in E. coli
Published on: July 30, 2014
24.1K
11:31Establishment of a High-throughput Setup for Screening Small Molecules That Modulate c-di-GMP Signaling in Pseudomonas aeruginosa
Published on: June 30, 2016
8.4K
相关概念视频
01:22Bioreactor Controls-III
67
Strain improvement is a foundational strategy in industrial microbiology aimed at maximizing microbial productivity, particularly because natural isolates typically yield commercially valuable products in very low concentrations. Although optimizing the culture medium and environmental conditions can improve yields, these adjustments are inherently limited by the organism’s genetic potential. As a result, the focus shifts toward genetic modifications to enhance biosynthetic capacity. The...
67
01:28Methods of Medium Optimization
70
Optimizing growth media enhances microbial proliferation and maximizes product yield. Statistical experimental design methodologies provide structured and reproducible approaches, offering progressively higher levels of robustness and efficiency.The One-Factor-at-a-Time (OFAT) MethodThe One-Factor-at-a-Time (OFAT) method involves adjusting a single variable while keeping all others constant. However, it cannot detect interactions between variables, often leading to suboptimal outcomes when...
70
01:14Scale-Up Processes
105
The scale-up of microbial fermentation processes is essential in industrial biotechnology, allowing the transition from laboratory-scale experiments to commercial-scale production while aiming to maintain product yield and quality. This process requires meticulous adjustment of equipment design, process parameters, and contamination control strategies to accommodate increasing culture volumes.At the laboratory scale, cultures are typically maintained in 1 to 10-liter glass or autoclavable...
105
01:27Upstream Processing
97
Upstream processing represents a critical phase in biomanufacturing, wherein biological systems such as microorganisms, mammalian cells, or insect cells are cultivated to produce therapeutic proteins, vaccines, enzymes, or other biologically derived products. This phase encompasses all steps from the selection and genetic manipulation of the production organism to the cultivation of cells in bioreactors under tightly controlled environmental conditions.Host Selection and Genetic OptimizationThe...
97